桑丁氧化还原酶在内皮功能障碍的发病过程中的作用:最新情况
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India.
Current hypertension reviews
|February 6, 2024
概括
赞丁氧化还原酶 (XOR) 抑制可减少活性氧物种 (ROS),并可治疗内皮功能障碍. 这篇评论探讨了XOR的XOR.
科学领域:
- 心血管科学 心血管科学
- 生物化学 生物化学
- 病理生理学 病理生理学
背景情况:
- 丁氧降解酶 (XOR) 是尿酸生产和反应性氧物种 (ROS) 生成的关键.
- 过多的ROS有助于高血压,动脉样硬化和心血管疾病.
- 人们越来越认识到XOR在炎症和内皮功能障碍中的作用.
研究的目的:
- 审查XOR和血管内皮功能障碍之间的关联.
- 探索XOR在慢性炎症和ROS介导的内皮损伤中的作用.
- 讨论动脉样硬化疾病中内皮功能障碍的预防和治疗策略.
主要方法:
- 基于证据的文献评论.
- 对XOR抑制及其对ROS和内皮功能影响的研究分析.
- 对XOR在血管疾病发病过程中的作用进行当前研究的综合分析.
主要成果:
- 过度生产XOR会导致炎症和ROS,导致内皮损伤.
- XOR活性与内皮功能障碍 (ED) 有关,在糖尿病,高血压和心血管疾病中很常见.
- 通过减少ROS和氧化应激,XOR抑制可能会减少ED.
结论:
- XOR在血管内皮功能障碍中起着重要作用.
- 准XOR为动脉样硬化疾病提供了潜在的治疗策略.
- 需要进一步的研究来澄清XOR在血管健康和疾病中的双重作用.
相关概念视频
Oxidation of Phenols to Quinones
3.0K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.0K
Electron Transport Chain: Complex III and IV
7.5K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
7.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
Phase I Oxidative Reactions: Overview
273
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
273


